Mskcc Renal Cell Carcinoma Risk Stratification

Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis.

Mskcc renal cell carcinoma risk stratification.

Motzer md is a medical oncologist at memorial sloan kettering cancer center. It is appropriate for patients who have undergone either radical nephrectomy complete surgical removal of a kidney or partial nephrectomy surgical removal of the cancerous. Our kidney cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for newly diagnosed renal cell carcinoma a type of kidney cancer. The two scores of 5 respectively 7 items are the only clinical judgment tools that address survival of patients with metastatic renal cell carcinoma.

Motzer s research focuses on renal cell carcinoma germ cell tumors and bone marrow and blood cell. This health tool determines survival in the case of patient with metastatic renal cell carcinoma based on their clinical and laboratory data. It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc. Who can use this tool.

The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail.